Overview
Technical Support: factevents@factglobal.org or 402-920-7001
This FREE webinar is the curtain opening of FACT Audit and Assessment Services, a solution provided by FACT Consulting. Cell and gene sponsors, license holders, manufacturers, registries, collection sites, processing laboratories, and treatment sites are invited to learn how this solution increases the return on investment in site assessments via specific, high-value benefits.
As reported extensively, the current industry qualification and auditing approach for cell and gene therapies is unsustainable and may delay or prevent patient access. FACT Consulting confirmed via a recent pilot project that its services can rapidly assess accredited and non-accredited sites’ ability to participate in a company’s network, perform assessments on behalf of industry, and reduce the duplicative audit burden on healthcare sites while increasing the quality of their services. It is a win-win-win solution that reduces the audit burden on industry and sites, allowing them to serve more patients.
At the conclusion of this live activity, participants will be able to:
-
Explain why FACT Audit & Assessment Services benefit industry and accredited and non-accredited healthcare institutions.
-
Discuss the FACT assessment process and deliverables provided to clients and assessed sites.
-
Evaluate the Voice of the Customer’s experience with the pilot assessments from the perspective of industry and cell collection sites.
-
Provide guidance on how to initiate assessment services and obtain institutional approval to leverage reports.
Speakers
Kim Kasow, DO
Medical Director, University of North Carolina at Chapel Hill
University of North Carolina | Bone Marrow and Stem Cell Transplant Program
Dr. Kim Kasow is the Director of Pediatric Bone Marrow Transplant at UNC with a primary clinical research interest in providing hematopoietic cell transplantation to patients with sickle cell disease. She is the Associate Director of Quality Initiatives for the UNC BMTCTP adult and pediatric program and the Associate Director of Quality for the UNC Advanced Cellular Therapeutics Facility.
She is a current member of the FACT Board of Directors, serving as the Treasurer, the Chair of the FACT Finance and Quality Management Committees, and Vice-chair of the FACT Technology Committee. Dr. Kasow is also a member of the Cellular Therapy Accreditation Committee. Dr. Kasow has served as a Clinical Hematopoietic Cellular Therapy, Clinical Immune Effector Cellular Therapy, and Marrow Collection FACT inspector since 2006.
$i++ ?>
Liz Ferraro
Manager, FACT Audit & Assessment Services
FACT
$i++ ?>
Nick Tsourides
Director of Quality & Compliance
Johnson & Johnson
$i++ ?>
Diane Bullock
Quality Manager, Stem Cell Transplant & Cellular Therapy Program
University of Rochester Medical Center | Strong Memorial Hospital
Diane Bullock is the Quality Manager for the Stem Cell Transplant & Cellular Therapy Program at the University of Rochester Medical Center, Strong Memorial Hospital in Rochester, NY. She has a medical technologist background with 20+ years of experience maintaining compliance with regulatory agencies such as the FDA, NYSDOH and FACT.
$i++ ?>